Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Andrew

Showing results (741-750 of 866) with videos related to

Pageof 87
Sort By:
Blood|October 15, 2011
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsLuca Malcovati, Elli Papaemmanuil, David T Bowen, et al.
Nucleic Acids Research|May 1, 2013
Single-cell paired-end genome sequencing reveals structural variation per cell cycleThierry Voet, Parveen Kumar, Peter Van Loo, et al.
Science (New York, N.Y.)|October 11, 2014
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencingJianjun Zhang, Junya Fujimoto, Jianhua Zhang, et al.
Nature Genetics|April 29, 2008
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingPeter J Campbell, Philip J Stephens, Erin D Pleasance, et al.
American Journal of Human Genetics|March 18, 2008
SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndromeGregor D Gilfillan, Kaja K Selmer, Ingrid Roxrud, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Oxazolidinones as novel human CCR8 antagonistsJian Jin, Yonghui Wang, Feng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2018
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid LeukemiaKiyomi Morita, Hagop M Kantarjian, Feng Wang, et al.
JAMA Oncology|April 7, 2022
Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical TrialDaniel M Halperin, Suyu Liu, Arvind Dasari, et al.
Nature Medicine|August 15, 2018
Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancerYonathan Lissanu Deribe, Yuting Sun, Christopher Terranova, et al.
Nature Medicine|June 13, 2018
Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancerYonathan Lissanu Deribe, Yuting Sun, Christopher Terranova, et al.
Pageof 87

Showing results (741-750 of 866) with videos related to

Sort By:
Pageof 87
Blood|October 15, 2011
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsLuca Malcovati, Elli Papaemmanuil, David T Bowen, et al.
Nucleic Acids Research|May 1, 2013
Single-cell paired-end genome sequencing reveals structural variation per cell cycleThierry Voet, Parveen Kumar, Peter Van Loo, et al.
Science (New York, N.Y.)|October 11, 2014
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencingJianjun Zhang, Junya Fujimoto, Jianhua Zhang, et al.
Nature Genetics|April 29, 2008
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingPeter J Campbell, Philip J Stephens, Erin D Pleasance, et al.
American Journal of Human Genetics|March 18, 2008
SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndromeGregor D Gilfillan, Kaja K Selmer, Ingrid Roxrud, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Oxazolidinones as novel human CCR8 antagonistsJian Jin, Yonghui Wang, Feng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2018
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid LeukemiaKiyomi Morita, Hagop M Kantarjian, Feng Wang, et al.
JAMA Oncology|April 7, 2022
Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical TrialDaniel M Halperin, Suyu Liu, Arvind Dasari, et al.
Nature Medicine|August 15, 2018
Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancerYonathan Lissanu Deribe, Yuting Sun, Christopher Terranova, et al.
Nature Medicine|June 13, 2018
Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancerYonathan Lissanu Deribe, Yuting Sun, Christopher Terranova, et al.
Pageof 87